Expression of the murine cytomegalovirus glycoprotein H by recombinant vaccinia virus

References

1. Arnold B., Messerle M., Jatsch L., Kühlbeck G., Koszinowski U. H. 1990; Transgenic mice expressing a soluble foreign H-2 class I antigen are tolerant to allogeneic fragments presented by self class I but not the whole membrane-bound alloantigen. Proceedings of the National Academy of Sciences. U.S.A 87:1762–1766
   [Google Scholar]
2. Blacklaws B. A., Krishna S., Minson A. C., Nash A. A. 1990; Immunogenicity of herpes simplex virus type 1 glycoproteins expressd in vaccinia virus recombinants. Virology 177:727–736
   [Google Scholar]
3. Borysiewicz L. K., Hickling J. K., Graham S., Sinclair J., Cranage M. P., Smith G. L., Sissons J. G. 1988; Human cytomegalovirus-specific cytotoxic T cells. Journal of Experimental Medicine 168:919–931
   [Google Scholar]
4. Britt W. J., Vugler L., Butfiloski E. J., Stephans E. B. 1990; Cell surface expression of human cytomegalovirus (HCMV) gp55-116 (gB): use of HCMV-recombinant vaccinia virus-infected cells in analysis of the human neutralizing antibody response. Journal of Virology 64:1079–1085
   [Google Scholar]
5. Chirgwin J. M., Przybala A. E., Macdonald R. J., Rutter W. J. 1979; Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18:5294–5299
   [Google Scholar]
6. Chou S. 1992; Molecular epidemiology of envelope glycoprotein H of human cytomegalovirus. Journal of Infectious Diseases 166:604–607
   [Google Scholar]
7. Cranage M. P., Kouzarides T., Bankier A. T., Satchwell S., Weston K., Tomlinson P., Barrell B., Hart H., Bell S. E., Minson A. C., Smith G. L. 1986; Identification of the human cytomegalovirus glycoprotein B gene and induction of neutralizing antibodies via its expression in recombinant vaccinia virus. EMBO Journal 5:3057–3063
   [Google Scholar]
8. Cranage M. P., Smith G. L., Bell S. E., Hart H., Brown C., Bankier A. T., Tomlinson P., Barrell B. G., Minson T. C. 1988; Identification and expression of a human cytomegalovirus glycoprotein with homology to the Epstein-Barr virus BXLF2 product, varicella-zoster virus gpIII, and herpes simplex virus type 1 glycoprotein H. Journal of Virology 62:1416–1422
   [Google Scholar]
9. Devereux J., Haberli P., Smithies O. 1984; A comprehensive set of sequence analysis programs for the VAX. Nucleic Acids Research 12:387–395
   [Google Scholar]
10. Drillien R., Spehner D. 1983; Physical mapping of vaccinia virus temperature-sensitive mutations. Virology 131:385–393
    [Google Scholar]
11. Ebeling A., Keil G. M., Knust E., Koszinowski U. H. 1983; Molecular cloning and physical mapping of murine cytomegalovirus DNA. Journal of Virology 47:421–433
    [Google Scholar]
12. Elliott R., Clark C., Jaquish D., Spector D. 1991; Transcription analysis and sequence of the putative murine cytomegalovirus DNA polymerase gene. Virology 185:169–186
    [Google Scholar]
13. Forrester A. J., Sullivan V., Simmons A., Blacklaws B. A., Smith G. L., Nash A. A., Minson A. C. 1991; Induction of protective immunity with antibody to herpes simplex virus type 1 glycoprotein H (gH) and analysis of the immune response to gH expressed in recombinant vaccinia virus. Journal of General Virology 72:369–375
    [Google Scholar]
14. Ghiasi H., Kaiwar R., Nesburn A. B., Wechsler S. L. 1992; Baculovirus-expressed glycoprotein H of herpes simplex virus type 1 (HSV-1) induces neutralizing antibody and delayed type hypersensitivity responses, but does not protect immunized mice against lethal HSV-1 challenge. Journal of General Virology 73:719–722
    [Google Scholar]
15. Ho M. 1991 Cytomegalovirus: Biology and Infection New York: Plenum Press;
    [Google Scholar]
16. Hutchinson L., Browne H., Wargent V., Davis-Poynter N., Primorac S., Goldsmith K., Minson A. C., Johnson D. C. 1992; A novel herpes simplex virus glycoprotein, gL, forms a complex with glycoprotein H (GH) and affects normal folding and surface expression of gH. Journal of Virology 66:2240–2250
    [Google Scholar]
17. Jonjić S., Del Val M., Keil G. M., Reddehase M. J., Koszinowski U. H. 1988; A nonstructural viral protein expressed by a recombinant vaccinia virus protects against lethal cytomegalovirus infection. Journal of Virology 62:1653–1658
    [Google Scholar]
18. Keil G. M., Ebeling-Keil A., Koszinowski U. H. 1984; Temporal regulation of murine cytomegalovirus transcription and mapping of viral RNA synthesized at immediately early times after infection. Journal of Virology 50:784–795
    [Google Scholar]
19. Keil G. M., Fibi M. R., Koszinowski U. H. 1985; Characterization of the major immediate-early polypeptides encoded by murine cytomegalovirus. Journal of Virology 54:422–428
    [Google Scholar]
20. Kouzarides T., Bankier A. T., Satchwell S. C., Weston K., Tomlinson P., Barrell B. G. 1987; Sequence and transcription analysis of the cytomegalovirus DNA polymerase gene. Journal of Virology 61:125–133
    [Google Scholar]
21. Loh L. C., Qualtiere L. F. 1988; A neutralizing monoclonal antibody recognizes an 87K envelope glycoprotein on the murine cytomegalovirus virion. Virology 162:498–502
    [Google Scholar]
22. Mackett M., Smith G.L. 1984; General method for production and selection of infectious vaccinia virus recombinants expressing foreign genes. Journal of Virology 49:857–864
    [Google Scholar]
23. Pachl C., Probert W. S., Hermsen K. M., Masiarz F. R., Rasmussen L., Merigan T. C., Spaete R. R. 1989; The human cytomegalovirus strain Towne glycoprotein H gene encodes glycoprotein p86. Virology 169:418–426
    [Google Scholar]
24. Pass R. F. 1991; Clinical importance of CMV. In Progress in Cytomegalovirus Research pp. 3–15 Landini M. P. Edited by Amsterdam: Elsevier;
    [Google Scholar]
25. Rapp M., Messerle M., Bühler B., Tannheimer M., Keil G. M., Koszinowski U. H. 1992; Identification of the murine cytomegalovirus glycoprotein B gene and its expression by recombinant vaccinia virus. Journal of Virology 66:4399–4406
    [Google Scholar]
26. Spaete R. R., Thayer R. M., Probert W. S., Masiarz F. R., Chamberlain S. H., Rasmussen L., Merigan T. C., Pachl C. 1988; Human cytomegalovirus strain Towne glycoprotein B is processed by proteolytic cleavage. Virology 167:207–225
    [Google Scholar]
27. Spaete R. R., Perot K., Scott P. I., Nelson J. A., Stinski M. F., Pachl C. 1993; Co-expression of truncated human cytomegalovirus gH with the UL 115 gene product or the truncated human fibroblast growth receptor results in transport of gH to the cell surface. Virology 193:853–861
    [Google Scholar]
28. Spear P. G. 1985; Glycoproteins specified by herpes simplex viruses. In The Herpesviruses pp. 315–356 Roizman B. Edited by New York: Plenum Press;
    [Google Scholar]
29. Stürzl M., Roth W. K. 1990; ‘Run-off’ synthesis and application of defined single-stranded DNA hybridization probes. Analytical Biochemistry 185:164–169
    [Google Scholar]
30. Tabor S., Richardson C. C. 1987; DNA sequence analysis with a modified bacteriophage T7 DNA polymerase. Proceedings of the National Academy of Sciences, U.S.A 84:4767–4771
    [Google Scholar]
31. Xu J., Dallas P. B., Lyons P. A., Shellam G. R., Scalzo A. A. 1992; Identification of the glycoprotein H gene of murine cytomegalovirus. Journal of General Virology 73:1849–1854
    [Google Scholar]